drugset / Trial / NCT00419796

Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

NCT00419796

Phase 4 Completed 78 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized study will compare the effect of lumiracoxib, ibuprofen and placebo on 24-hour blood pressure profile and on urinary excretions of eicosanoids in controlled hypertensive patients who have osteoarthritis.

Timeline

Start
2006-11
Primary completion
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumiracoxib Small molecule 100 mg

Indications